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Abstract. We present a new human osteosarcoma cell
line designated OHS-4. These cells showed a high alka-
line phosphatase activity that is not regulated by 1,25 di-
hydroxyvitamin D3. They exhibited a sensitive adenyl-
ate cyclase response to parathyroid hormone but not to
prostaglandin E2 or human calcitonin. By Northern blot
analysis we could detect type I collagen mRNA but
none for type III collagen. The cells were able to pro-
duce human osteocalcin at a maximum level of 35 ng
per million cells when exposed to 2 .4 nM 1,25-dihy-
droxyvitamin D3 for 96 h. We purified this protein from
conditioned media using successive chromatography
S
TUDIES on osteoblasts in vitro have been conducted
largely on the rat osteosarcoma cell lines ROS 17/2
and UMR-106 (24, 27) . Several arguments prompted
us to attempt to establish and characterize a humanosteosar-
coma cell line. Differences in hormonal regulation between
species have been described (6). Several human osteosar-
coma cell lines have been studied (3, 11, 18, 32, 33) but none
of them showed all the osteoblastic features described in the
well-characterized rat osteosarcoma cell lines ROS 17/2 .8.
Among the humanosteosarcoma cell lines studied so far, two
have been more extensively characterized in terms of their
osteoblastic features: the SAOS-2 (26) and the MG-63 (19),
and these cellsare now quite widely used. The SAGS-2 cells
display many osteoblastic characteristics such as high alka-
line phosphatase activity, parathyroidhormone (PTH)-sensi-
tive adenylate cyclase, but they do not produce the bone spe-
cific protein: osteocalcin also called bone glaprotein (BGP).'
On the contrary, the MG-63 cells described by Lajeunesse
et al. (19) produce some BGP but they have very little alka-
line phosphatase activity and no PTH-sensitive adenylate cy-
clase activity; secondly, they are not able to form bone when
injected into nude mice. Finally, the need for a source of os-
teoblast-specific proteins coming from a well-characterized
human osteoblastic cell line was a decisive argument. In this
paper, we describe a new humanosteosarcoma cell line, des-
ignated OHS-4, with the following osteoblastic characteris-
tics: high alkaline phosphatase activity, PTH-responsive ad-
enylate cyclase, synthesis of type I collagen, synthesis of
BGP regulated by 1,25(OH)2D3, and the ability to produce
mineralized tissue when injected into athymic animals.
1. Abbreviations usedin thispaper: BGP, bone gla protein; CT, calcitonin;
NCS, newborn calf serum.
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and assessed its identity by partial amino acid sequenc-
ing. When injected into nude mice, the cells retained
their osteogenic activity and developed calcified tumors.
After Von Kossa staining, we observed nonmineralized
osteoid deposits and mineralized deposits with a struc-
ture similar to that of trabecular bone by light micros-
copy. On the basis of its osteoblastic characteristics,
this new osteosarcoma cell line may represent the hu-
man counterpart of the ROS 17/2 cell line. This cell
line represents a valuable model for the isolation and
characterization of human bone specific proteins.
Materials and Methods
The human osteosarcoma cell line MG-63 was obtained from the American
Type Culture Collection (Rockville, MD), RPMI 1640 medium, newborn
calf serum (NCS), antibiotics, and trypsin solution were obtained from Ir-
vine Scientific (Irvine, CA). 1,25(OH)2D3 was generously provided by Dr.
M. Uskokovik Hoffmann-La Roche (Nutley, NJ). Tissue culture dishes
were purchased from Falcon Labware (Oxnard, CA) . Human PTH(1-34),
was from Bachem (Torrance, CA). Prostaglandin E2 (PGE2), phospho-
enolpyruvate, pyruvate kinase, p-nitrophenylphosphate, CAMP, and ATP
were obtained from Sigma Chemical Co. (St. Louis, MO). Human calcito-
nin was provided by Ciba-Geigy Ltd. (Basel, Switzerland). a[32P]ATP,
[8-3H]cAMP, and [a3zP]dCTP were purchased from Amersham Chenu-
cals (Arlington Heights, IL) . Random primed DNA labeling kits were ob-
tained from Boehringer (Mannheim, FRG). All reagents were analytical
grade unless otherwise stated.
Cloningofthe Human Osteosarcoma CellLine
Clones were isolated from a human osteosarcoma cell line OHS-50, which
was a generous gift from Dr. Fodstad (12) (Dethorske Radium Hospital,
Norway) by distributing trypsin-treated cells inmicrotiter plates (0.4 ml ca-
pacity; Falcon Labware) at an average dilution ofone cell/well. Wells con-
taining only one cell (established by microscopic observation) were main-
tained until a monolayer was formed, then the contents were transferred to
60-mm culturedishes. Analternativeprocedure using cloning cylinders was
used after distributing trypsin treated cells at decreasing dilutions of 100:5
cells per 100-mm plate.
Osteosarcoma CellCulture
MG-63 cells and OHS-4 clones were grown in RPMI 1640 medium with
10% NCS, 2 mM L-glutamine, and 1% antibiotic/antimycotic solution. The
cultures were incubated at 37°C in a humidified atmosphere of95% air and
5% CO2. The medium was changed three to four times weekly and the
cells were subcultured once a week.
For measurement of BGP production, cells were grown to confluency in
35-mm culture dishes. These cultures were then placed in 2 ml fresh me-
dium containing 2% NCS for 24 h and then into 1.2 ml fresh serum-free
577medium. At this point, the cells were treated with 1,25(OH)2D3 diluted in
absolute ethanol to the concentration of 2.4 nM or with 10 WI of absolute
ethanol/ml medium as the control. Every subsequent 24 h, the conditioned
media was removed and the cultures weregiven fresh serum-free media with
the same amount of 1,25(OH)2D3 or absolute ethanol. For each day over
7 d, twoplateswere counted. Cell counts wereperformed on trypsinized cell
suspensionsusingaCoultercounter (Coulter ElectronicsInc., Hialeah, FL).
Growth Properties
Cells were plated at different densities: 5,000, 10,000, and 20,000 cells/cm2
in microtiter plates. Medium was changed every 48 h. Growth was moni-
tored over a period of 8 d.
RNA Isolation and Blot
RNA was extracted from cell cultures by the guanidium isothiocyanate
method (7). 20 gg of RNA were electrophoresed on a 0.8% agarosegel con-
taining 2.2 M formaldehyde and blotted onto a Hybond sheet. The filters
were hybridized at 42°C with the appropriate probe. cDNA for procollagen
al(I) and al(III) were a kind gift from Dr. Ramirez (8, 9) .
Identity of the Protein Measured by Human
BGP Radioimmunoassay
80 100-mm plates of OHS-4 were grown to confluency and treated with
vitaminD3 during 4 d as described above. Conditioned media from the last
3 d was collected. This media was passed over an affinity column with an-
tibodies directed against calf BGP. The peak containing the immunoreac-
tivity was eluted through a reverse phase HPLC column as already de-
scribed (23) . The peak collected was subjected to automatic Edman
degradations using a gas phase sequencer (model 470A; Applied Bio-
systems, Inc., Foster City, CA).
Radioimmunoassay
The procedure used for human BGP radioimmunoassay has been described
elsewhere (25). Results reported in this paper are averages ofthree determi-
nations.
Alkaline Phosphatase Determination
Cells were seeded at a density of 40,000 cells/cm2 in microtiter plates. Af-
ter 24 h, the medium was replaced with onecontaining 2% heat-inactivated
FBS. The cells were incubated for 72 h with daily change of medium. After
72 h, the cells were washed with PBS, pH 7.6, trypsinized and collected.
The cells were then suspended in TMX buffer (10 mM Tris HCl, pH 7.4,
1 MM MgC12, 20 pM ZnC12, 0.02% (wt/vol) NaN3, and 0.1% Triton-X
199), and sonicated for 30 s. The sonicate was centrifuged 30min at 9,000 g
at 4°C. Alkaline phosphatase was routinely determined by measuring the
release ofp-nitrophenol from p-nitrophenylphosphate spectrophotometri-
cally (410 nM at 37°C) by the method of Lowry et al. (20). Protein was
measured by the Pierce BCA protein assay kit (Pierce Chemical Co., Rock-
ford, IL) (31). Results were expressed in micromoles/minute/milligram
protein.
Adenylate Cyclase Activity
Adenylate cyclase assays were carried out on cells at confluency. The cells
were rinsed with 10 ml of homogenizing medium consisting of 0.25 M su-
crose, 1 mM DTT, and 1 mM Na2 EDTA in 25 mM HCI, pH 8.2. Cells
were scraped from the surface of the flask with a plastic policeman and
homogenized in an all-glass, handheld tissue homogenizer (10 strokes) in
ice. The reaction mixture consisted of 25 mM Tris HCI, pH 7.4, 0.1 mM
cAMP, 5 mM phosphoenol pyruvate, 3 U pyruvate kinase, 30 mM KCI,
9 MM M9Cl2, 0.1 g/literBSA, 0.1 mM [a32P]ATP and hormone as indicated
in 100 Al reaction volume. The reaction was initiated by addition of cell
homogenates (50-100 )Ag protein) and allowed to proceed for 10 min at
37°C. The reaction was stopped by addition of 10 mM ATP followed by
boiling for 3 min. The cAMP formed in the reaction was then separated
from the other labeled molecules in the mixture by chromatography on
columns of Dowex AG 50 W x 8 and alumina as described by Salomon
et al. (28). The ["P]CAMP was counted after addition of 10 ml Instagel in
ascintillationcounter(model LS 233;BeckmanInstruments, Fullerton, CA).
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Transplantation ofClonal Osteogenic Sarcoma Lines
OHS-4 cells weredetachedfrom the plates by trypsinization, then collected
and resuspended in a small volume (5-6 x 106 cells/l ml media). These
suspensions were injected subcutaneously into six nude mice (three male/
three female).
Biochemical Analysis ofthe 71imors
Halfofthe tumors were dissected to dissociate soft tissue from mineralized
tissue. Mineralized tissue was washed with PBS saturated with hydroxyapa-
tite. The mineralized tissue was freeze dried and weighed before acid extrac-
tion using a 10-fold (vol/wt) excess of 10% formic acid. The amount of
phosphorus present in the supernatant was determined by the colorimetric
method of Chen et al. (5). Calcium was determined by atomic absorption
spectrophotometry. Human BGP was measured by radioimmunoassay on
freeze-dried samples of 20-50 1LI of formic acid extract.
Light Microscopy
Thetumors were transferred directly from the host animal into 70% ethanol
and fixed for 48 hours. They were then embedded in glycol methacrylate
and sectioned. The sections (8 ftm) were stained with hematoxylen eosin
and by the method of Von Kossa.
Bone Formation In Vitro
The cells were plated in 100-mm plates in normal culture medium. At
confluency, the medium was replaced by RPMI 1640 containing 10% NCS,
2 mM L-glutamine, 1% antibiotic/antimycotic solution with the addition of
5014g/ml ascorbic acid and 10 mM (i-glycerophosphate as described by Bel-
lows et al. (2). The media were changed every second day. The cells were
maintained in these conditions for 30 d. At the end of the experiment, the
medium was removed, the cells washed with distilled water and fixed over-
night in neutral buffer formalin, and stained with Von Kossa technique. Af-
ter staining, the cells were observed by light microscopy.
Results
Cloning and Growth Properties
We obtained -20 clones from the OHS-50 cells by the
method describedabove. Surprisingly, most of theclones un-
derwent terminal differentiation. We were able to maintain
eightviable clonesandmade ourselectionforfurtherstudyon
the basis ofBGPproduction. The cells selected were called
OHS-4 andpresentedaquite homogeneous population with
cuboidal shape. Growth properties are illustrated in Fig. 1.
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Figure 1. Growth curve for OHS-4 cells. The cells were plated at
different densities. (o) 5,000; (") 10,000; and (A) 20,000 cells/
cm2. Cell numbers were then determined as number of cells/cm2.TableL Alkaline PhosphataseActivity in Human
Osteogenic Sarcoma Cell Lines
Cell line
￿
Alkaline phosphatase activity
pmol/min per mg protein
MG-63
￿
0.02 t 0.05
SAOS-2
￿
2 .4 f 0.25
OHS-4
￿
2 .5 t 0.14
Cells were maintained for72 h in medium containing 2% heat-inactivated se-
rum. Cells were harvested after trypsinization. Theintracellular alkaline phos-
phatase was extracted by sonication and centrifugation. Aliquots of the
supernatant were assayed for alkaline phosphatase activity by the method of
Lowry et al. (19). Another aliquot was assayed for protein. Results were aver-
ages of two different wells with duplicate determinations and are expressed
t SE per mg protein.
The cells were confluent at a density of 70,000 cells/cmz.
The doubling time was calculated from the slopes of the
growth curves and corresponded to 39 h, the saturation den-
sity was 250,000 cell/cm' .
Alkaline Phosphatase Activity
Table I shows intracellular alkaline phosphatase activity pro-
duced in different human osteosarcoma cell lines. OHS-4
cells as well as the SAOS-2 cells produced a high alkaline
phosphatase activity -100-fold higher than that of MG-63
cells. When cultivated in the presence of an increased con-
centration of 1,25(OH)2D3 , OHS-4 cells displayed very dif-
ferent sensitivity towards vitamin D3 in comparison to the
MG-63 cells (Fig. 2, a and b). As reported previously (13),
we also observed a net decrease in proliferation for the MG-
63 and a dose-dependent increase in alkaline phosphatase
activity with a maximum reached at 10 nM 1,25(OH)2D3.
In comparison, the OHS-4 cellsshowed no significant differ-
ences in alkaline phosphatase activity between control and
vitamin D3-treated cells.
Adenylate Cyclase Activity
Table II summarizes the extent ofstimulation ofthe adenylate
cyclase activity in the presence of PTH, PGE2 , and calci-
tonin . The high degree ofstimulation ofthe adenylate cyclase
activity by PTH in the OHS-4 cells was of the same order
of magnitude as that observed in ROS 17.2/8 cells. Fig. 3
shows a dose-dependent stimulation of the adenylate cyclase
activity, the half-maximal stimulation was obtained at 5 x
10-a M PTH . In a parallel experiment with MG-63 cells we
could not detect any stimulation of the adenylate cyclase ac-
tivity either by PTH orhuman calcitonin (results not shown) .
Analysis of Type 1 and III Collagen Expression
The Northern blot analysis of total RNA obtained from
OHS-4 cells is shown in Fig. 4. We were not able to detect
any collagen type III but we did obtain a good signal for type
I collagen. In normal osteoblast cells collagen type III is not
coexpressed with collagen type I (29) .
Isolation ofHuman BGPfrom OHS-4 Media
To prove that the protein measured by RIA was indeed hu-
man BGP and not contaminating calf BGP coming from
newborn calf serum, we isolated the protein from the condi-
tioned media of OHS-4 cells. After a first step of immuno-
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TableIL Adenylate Cyclase Responsiveness ofOHS-4 Cells
to PTH, Human Calcitonin (CT), and PGE2
Figure 2. Effects of 1,25(OH)2D3 on the activity of alkaline phos-
phatase in OHS-4 (a) andMG-63 (b) cells. MG-63 and OHS-4 cells
were plated at 20,000 cells/cmz in medium containing RPMI sup-
plemented with 10 % NCS. After 24 h the medium was removed and
the cells were fed with RPMI supplemented with 2 % heat-inacti-
vated denatured NCS and vitamin D3 (or carrier) at the indicated
concentration. The medium was changed every 24 h during 6 d. Af-
ter 6 d, the cells were treated as described in Materials and Meth-
ods. Each pointrepresents the mean oftwo different wells. Statisti-
cally significant differences from control values (p < 0.05) were
determined by t test.
Number of determinations 33.
Adenylate cyclase activity wasmeasured on cell homogenates (50-100 pg pro-
tein/assay) as described in Materials and Methods. Blanks were prepared by
adding cell homogenates after the stop solution. Values are the mean of at least
two determinations .
Treatment Adenylate cyclase activity
pmol/min per mg protein
Extent of stimulation
(hormone/control)
Control 5 .06 t 0.17 -
PTH 52 .66 f 8.54 10.5
PGE2 (10 nM) 6.82 f 0.46 1 .3
PGE2 (100 nM) 4.19 f 0.20 0.8
PGE2 (1 EUM) 5 .57 f 1 .36 1 .1
CT (100 nM) 6.46 f 1 .69 1 .3c
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Figure 3. Dose-dependent stimulation of PTH-sensitive adenylate
cyclase in OHS-4 cells . Adenylate cyclase was measured for 10 min
as described in Materials and Methods . Each point is the result of
at least two determinations .
affinity chromatography, the immunoreactive peak was sub-
jected to reverse phase chromatography. Fig . 5 a shows a
chromatogram of human BGP purified from bone, Fig . 5 b
shows the peak of human BGP obtained from the media .
These two proteins are eluted with the same percentage of
acetonitrile. Partial sequencing of the human BGP purified
from media identified the first residues of the protein as
Tyr 3-Gln4-x 5-Leu6 . This allowed us to discount contami-
nation by calf BGP since residues 3 and 4 of this BGP are
Asp-His .
In OHS-4 cells no basal level of BGP was detectable
(<0.67 ng/ml) . As shown in Fig . 6, OHS-4 cells treated with
2.4 nM 1,25(OH)2D3 produced BGP with a production of
35 ng/106 cells for OHS-4 . The OHS-50 cells from which
the OHS-4 were subcloned, treated in the same way in a par-
allel experiment, produced significantly less BGP, illustrat-
ing the efficacy ofthe subcloning process . In a similar experi-
ment using the MG-63 cells treated with vitamin D 3 we
could only detect 6 ng BGP/106 cells .
nmor Induction in NudeMice
8 wk after injection of cells into nude mice five out of six
animals had palpable tumors . Table III shows the biochemi-
cal composition of the mineralized part of the tumor . The
calcium content of these calcified tumors was in the range
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Figure 5. HPLC of immunoaffinity-purified BGP on a Vydac C4
column (4.6 x 25 cm) . Mobile phase : buffer A, 0.1% trifluoro-
acetic acid ; buffer B, 0.1% trifluoroacetic acid in (60:40) acetoni-
trile : H2O. Flow rate, 1 .0 ml/min . Temperature : 25°C . Samples
in 4M guanidine HCl were applied in 100% buffer A . After the
guanidine had passed through the column a linear gradient from 0
to 100% B was developed . (A) 10 i~g of human BGP from bone .
(B) 6.64 kg of immunoaffinity-purified BGP from OHS-4 cultures
treated with 2.4 nM 1,25(OH)2D3 in serum-free medium, during
4 d with daily changes .
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Figure 6. Rate of BGP secretion in 1,25(OH)2D 3-treated OHS-4
cells . Cultures received fresh medium containing 2.4 nM 1,25-
(OH)2D3 or vehicle every 24 h as described in Materials and Meth-
ods . Each point represents the average of two culture wells .
Figure 4. Northern blot analysis of type I
andIIImRNA collagen expressioninOHS-4
cells . RNA was extracted from confluent
plates of OHS-4 cells . 15 ug of total RNA
was run on an 0.8% agarose gel containing
2.2 M formaldehyde and blotted onto a Hy-
bond sheet . Filters were hybridized using
32plabeled ul(I) procollagen cDNA and
autoradiographed (A) . After autoradiog-
raphy the probe was boiled off and the
Northern blot was hybridized to a 32P-la-
beled al(III) procollagen cDNA and auto-
radiographed (B) .Table 111 . BiochemicalMeasurement on the TissueFormed inNude Mice after Injection ofOHS-4 Cells
ofthat found in human bone . With the exception of one sam-
ple, the Ca/P ratio in the mineralized tumor tissue was close
to the value of 1.6, which is usually found in hydroxyapatite .
We were able to detect human BGP in only two out of five
samples . Histologicalexamination ofcalcifiedtumors showed
an homogenous cell population with the appearance of sar-
coma tissue, some mitotic figures were observed (Fig. 7 a) .
After Von Kossa staining, we observed non-mineralized os-
teoid and mineral deposits with a structure similar to that of
the trabeculae (Fig . 7 b) . No cartilaginous component could
be discerned in any ofthe samples . In vitro, after 30 d in cul-
ture, the cells did not show any nodular structure . These cells
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did not lay down any calcified extracellular matrix . This dis-
crepancy with the osteogenic ability of these cells found in
vivo should be further investigated, in particular by using
collagen coated surfaces .
Discussion
This paper reports on the osteoblastic features of a new hu-
man osteosarcoma cell line OHS-4 and compares them with
the characteristic features of the other human osteosarcoma
cell lines, SAOS-2 and MG-63 . In the temporal program of
bone-specific protein expression associated with mineraliza-
Figure 7 . Section of the tumor obtained after implantation of OHS-4 cells into nude mice . (a) Light microscopy of a hematoxylin and
eosin section . 144x . (b) Light microscopy of a Von Kossa-stained section . 144x . Bars : (a and b) 100 AM .
58 1
Sample Calcium
uglmg tissue
Phosphate
Calcium/
Phosphorus Human BGP
ng/mg tissue
1 218.2 t 3 .3 312.1 t 6.1 1 .66 3.9
2 244.2 t 9.7 167 .3 t 1 .6 3.47 <2
3 227 .2 t 7.0 59 .3 t 1 .4 9.09 <2
4 161 .1 t 4.1 140 .5 t 6.7 2.72 <2
5 178.5 f 3 .0 203.2 t 17.9 2.09 4.1
Human bone 285 .5 f 3.2 354.9 t 8.9 1 .91 810.0
264.6 f 11.0 388 .7 t 3 .0 1 .61 800.0tion, alkaline phosphatase appears first and has a key role
in matrix mineralization. The cell line OHS-4 expresses a
high alkaline phosphatase levelcomparable to that expressed
in SAOS-2 cells. In both cell lines this alkaline phosphatase
activity could not be modulated by 1,25-dihydroxyvitamin
D3 (22) . Cell lines other than MG-63 have been shown to
display a high sensitivity to vitamin D3 (13-21) . Spiess et
al . (31) proposed that the osteoblastic cell response to vita-
min D3 depends on their phenotypic state of differentiation.
These differences added to the differences in basal level of
alkaline phosphatase activity in MG-63 and OHS-4 cells il-
lustrate that we are dealing with cells which are clearly at
a different stage in the osteoblastic lineage. OHS-4 as well
as ROS 17.2 and SAOS-2 cells possess a PTH-sensitive ade-
nylate cyclase, but no stimulation was observed when ex-
posed to PGE2 and calcitonin.
In contrast SAOS-2 cells possess a PGEz-sensitive ade-
nylate cyclase activity (4). Aubin et al. (1) have already de-
scribed in theiranalysis of different bone cell clones the exis-
tence of different cell types, one responding to both PGE2
and PTH and the other to PTH alone. The absence of a re-
sponse to PTH and calcitonin in the MG-63 cells is puzzling.
From other studies (17) we would have expected a change in
the adenylate cyclase sensitivity towards calcitonin .
The exclusive expression of type I collagen in OHS-4 is
consistent with the factthat osteoblastic cells only synthesize
this collagen type (29). In contrast, MG-63 cells produce
both types of collagen. The ratio of type I and III collagen
has been shown to be regulated by vitamin D3 in these cells
(14). This observation suggests that OHS-4 cells are more
mature cells. The production of BGP after treatment with
1,25(OH)2D3 reached a plateau after 96 hours for OHS-4
cells and then decreased over the next few days. This phe-
nomenon has already been described for the ROS 17/2 cells
(16). The maximal production of human BGP per million
ofcells is about200-fold less than that observed in ROS 17/2 .
This difference in production in vitro may be related to the
100-fold difference between circulating BGP levels in the rat
and in man. This ability to produce BGP was not observed
in the SAOS-2 cell line. Fraser et al. (15) described a mu-
tually exclusive production of human matrix GLA protein
(MGP) and BGP Therefore, it is possible that, as in the case
of the rat cell lines (ROS 17.2 and UMR-106), the BGP
production observed in OHS-4 excludes MGP production
and the inverse holdstrue for SAOS-2 cells. Information on
the production of other noncollagenous proteins secreted by
these different cell lines will shed some light on the further
classification of these cell lines in the osteoblastic lineage.
Finally, the ability of the OHS-4 cellsto produce mineral-
ized tumors when injected into nude mice is a very important
osteoblastic feature. Whereas Rodan et al . (26) described
that SAGS-2 cellsproduced nonmineralized tumors when in-
jected into nude mice, they were only able to describe pro-
duction of mineralized matrix typical of woven bone when
the cells were put into diffusion chambers. We showed a
clear development of mineralized tissue after injection ofour
cells into nude mice. The measurement of human BGP dis-
counts any possibility that the bone formed arose from the
host cells, no cross-reactivity was foundbetween mouse and
humanBGP When injected into nude mice, the MG-63 cells
were not able to produce calcified matrix, however the ma-
nipulation ofthis cell line by Dedhar et al. (10) led to a more
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differentiated cell type (MG-63 3A) which, unlike the parent
cell line, was able to produce mineralized matrix.
In conclusion, we present a new humanosteosarcoma cell
line, OHS-4, exhibiting all the osteoblastic features neces-
sary to fulfill the definition of an osteoblast-like cell. We be-
lieve that this cell line will provide a useful good model to
study hormone action on humanosteoblasts in vitro. We also
emphasize the diversity of the osteoblastic phenotype (27)
and present a comparison ofthis new cell line with other hu-
man osteosarcoma cell lines.
Through the description of these different phenotypes, we
present a panel of different models to study osteoblastic dif-
ferentiation and in particular to correlate one stage of dif-
ferentiation to the expression of a specific protein or enzy-
matic expression .
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